The Moat Index
Compare moats, side by side.
Two to four companies, scored on the same five investor questions from their SEC filings — so the comparison is apples to apples. The method is fully public.
OGN · Healthcare · No moat
Doesn't clear the bar
The returnsOnCapital component abstained: Not enough years of ROIC data to score returns on capital. The other four 20% weights were renormalized over the scored 80%.
ATRA · Healthcare · No moat
Doesn't clear the bar
The pricingPower component abstained: Not enough years of gross-margin data to score pricing power. The other four 20% weights were renormalized over the scored 80%.
WLSS · Healthcare · No moat
Doesn't clear the bar
The returnsOnCapital component abstained: Not enough years of ROIC data to score returns on capital. The other four 20% weights were renormalized over the scored 80%.
| Measure | OGN | TWST | ATRA | WLSS |
|---|---|---|---|---|
| Moat Score (0–100) | 36 (highest) | 36 (highest) | 36 (highest) | 35 |
| Methodology version | moat-index@3.0.0 | moat-index@3.0.0 | moat-index@3.0.0 | moat-index@3.0.0 |
| Business trend | 34 | 65 | 72 (highest) | 20 |
| Pricing power | 93 (highest) | 34 | — | 70 |
| Returns on capital | — | 0 (highest) | 0 (highest) | — |
| Balance-sheet safety | 0 | 55 (highest) | 46 | 28 |
| Capital discipline | 15 | 24 (highest) | 24 (highest) | 24 (highest) |
| Price vs. high estimate | 67% below high estimate | No price data | No price data | No price data |
| Market cap | $3.5B | $5.5B | $57.9M | $1.7M |
| Moat tier | No moat | No moat | No moat | No moat |
| Filings as of | FY2025 | FY2025 | FY2025 | FY2025 |